Lori M. Laffel

1988–2025 年に発表

200
論文数
32,791
被引用数
90
h 指数
191
i10 指数

被引用数

Lori M. Laffel の年別被引用数1984 年: 被引用 1 件1988 年: 被引用 5 件1989 年: 被引用 4 件1990 年: 被引用 7 件1991 年: 被引用 5 件1992 年: 被引用 9 件1993 年: 被引用 10 件1994 年: 被引用 10 件1995 年: 被引用 9 件1996 年: 被引用 21 件1997 年: 被引用 22 件1998 年: 被引用 23 件1999 年: 被引用 24 件2000 年: 被引用 33 件2001 年: 被引用 56 件2002 年: 被引用 47 件2003 年: 被引用 62 件2004 年: 被引用 57 件2005 年: 被引用 89 件2006 年: 被引用 88 件2007 年: 被引用 105 件2008 年: 被引用 104 件2009 年: 被引用 167 件2010 年: 被引用 137 件2011 年: 被引用 138 件2012 年: 被引用 143 件2013 年: 被引用 162 件2014 年: 被引用 177 件2015 年: 被引用 169 件2016 年: 被引用 151 件2017 年: 被引用 142 件2018 年: 被引用 271 件2019 年: 被引用 894 件2020 年: 被引用 1,145 件2021 年: 被引用 1,209 件2022 年: 被引用 1,164 件2023 年: 被引用 1,032 件2024 年: 被引用 1,595 件2025 年: 被引用 752 件2026 年: 被引用 47 件1985〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,985 件、この内訳の 28.6%イギリス: 引用元論文 889 件、この内訳の 8.5%イタリア: 引用元論文 517 件、この内訳の 5%中国: 引用元論文 503 件、この内訳の 4.8%オーストラリア: 引用元論文 466 件、この内訳の 4.5%カナダ: 引用元論文 457 件、この内訳の 4.4%ドイツ: 引用元論文 428 件、この内訳の 4.1%デンマーク: 引用元論文 282 件、この内訳の 2.7%オランダ: 引用元論文 253 件、この内訳の 2.4%スペイン: 引用元論文 241 件、この内訳の 2.3%スウェーデン: 引用元論文 224 件、この内訳の 2.2%フランス: 引用元論文 219 件、この内訳の 2.1%
0%28.6%その他 28.4%

分野

  • Medicine77.7%
  • Biochemistry, Genetics and Molecular Biology8.8%
  • Health Professions5%
  • Engineering1.9%
  • Psychology1.5%
  • Immunology and Microbiology1.3%
  • その他3.8%

トピック

  • Diabetes Management and Research20.1%
  • Diabetes and associated disorders9.3%
  • Pancreatic function and diabetes8.3%
  • Diabetes Treatment and Management4.7%
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients4.6%
  • Diabetes Management and Education4.3%
  • その他48.7%

共著者

全論文

検索で開く
  1. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Éric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2019 被引用: 3,797

  2. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julio Rosenstock, Banshi Saboo, Kohjiro Ueki, Guillermo E Umpierrez, Stuart A. Weinzimer, Moshe Phillip - The Lancet Diabetes & Endocrinology 2022 被引用: 725

  3. International Consensus on Use of Continuous Glucose Monitoring

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mauro Scharf, William V. Tamborlane, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2017 被引用: 2,026

  4. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 965

  5. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin de Bock, Daniel J. DeSalvo, J. Hans DeVries, Klemen Dovč, Francis J. Doyle, Laya Ekhlaspour, Naama Fisch Shvalb, Gregory P. Forlenza, Geraldine Gallen, Satish K. Garg, Dana Gershenoff, Linda Gonder‐Frederick, Ahmad Haidar, Sara Hartnell, Lutz Heinemann, Simon Heller, Irl B. Hirsch, Korey K. Hood, Diana Isaacs, David C. Klonoff, Olga Kordonouri, Aaron J. Kowalski, Lori M. Laffel, Julia Lawton, Rayhan Lal, Lalantha Leelarathna, David M. Maahs, Helen Murphy, Kirsten Nørgaard, David N. O’Neal, Sean M. Oser, Tamara K. Oser, Éric Renard, Michael C. Riddell, David Rodbard, Steven J. Russell, Desmond Schatz, Viral N. Shah, Jennifer L. Sherr, Gregg D. Simonson, R. Paul Wadwa, Candice Ward, Stuart A. Weinzimer, Emma G. Wilmot, Tadej Battelino - Endocrine Reviews 2022 被引用: 402

  6. Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cari Berget, Susan McCoy, Viral N. Shah, Halis Kaan Aktürk, Nicole Schneider, Hal Joseph, Prakriti Joshee, Christie Beatson, Bruce W. Bode, Brooke Narron, Tricia Lopez, Jordan E. Pinsker, Mei Mei Church, Kristin Castorino, Molly Piper, Jimena Pérez, Carol J. Levy, David W. Lam, Camilla Levister, Grenye O’Malley, Selassie Ogyaadu, Dushyanthy Arasaratnam, Mitchell Plesser, Emily Nosova, Suzan Bzdick, David W. Hansen, Sheri Stone, Ruth S. Weinstock, Irl B. Hirsch, Subbulaxmi Trikudanathan, Nancy Sanborn, Dori Khakpour, Anders L. Carlson, Amy Criego, Richard M. Bergenstal, Thomas Martens, Aimee Grieme, Jamie Hyatt, Alina Punel, Diane Whipple, Jennifer L. Sherr, Michelle Van Name, Michelle Brei, Melinda Zgorski, Amy Steffen, Lori Carria, Sanjeev N. Mehta, Lori M. Laffel, Lindsay Roethke, Margaret C. Fisher, Rebecca Ortiz La Banca, Lisa K. Volkening, Louise Ambler-Osborn, Christine Turcotte, Emily Freiner, Anuj Bhargava, Lisa Borg, Sarah A. MacLeish, Jamie Wood, Beth A. Kaminski, Terri Casey, Wendy Campbell, Daniel J. DeSalvo, Siripoom McKay, Mary Kylie DeLaO, Carolina Villegas, Thomas C. Jones, Barry Johns, Ashwini Gore, L Harvill ほか 24 名 - Diabetes Care 2021 被引用: 269

  7. Microneedle Aptamer-Based Sensors for Continuous, Real-Time Therapeutic Drug Monitoring

    著者: , , , , , , , , , , , , , , , , - Analytical Chemistry 2022 被引用: 199

  8. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes

    著者: - Diabetes/Metabolism Research and Reviews 1999 被引用: 1,368

  9. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes

    著者: , , , , , , , , , , , , , , , , , , , , - JAMA 2020 被引用: 425

  10. Exercise management in type 1 diabetes: a consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2017 被引用: 890

  11. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 被引用: 328

  12. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lori M. Laffel, Michelle L. Katz, Elvira Isganaitis, Sanjeev N. Mehta, Heidi Quinn, Nisha Naik, Zijing Guo, Lisa K. Volkening, Robert H. Slover, Gregory P. Forlenza, R. Paul Wadwa, G. Todd Alonso, Laurel H. Messer, Lindsey Towers, Katie Thivener, Cari Berget, Samantha Lange, Emily Jost, Maria Rossick-Solis, Desmond Schatz, Michael J. Haller, Paul Hiers, Laura M. Jacobsen, Madison B. Smith, Anastasia O’Neill, Jennifer Hosford, Alexis Perry, Stuart A. Weinzimer, Eda Cengiz, Jennifer L. Sherr, Kathryn Gibbons, Lori Carria, Melinda Zgorski, Thomas Danne, Torben Biester, Olga Kordonouri, Thekla von dem Berge, Sarah Biester, K Remus - Nature Medicine 2020 被引用: 237

  13. Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials

    著者: , , , , , , , , , , - Diabetes Care 2018 被引用: 357

  14. Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association

    著者: , , , , , , , - Diabetes Care 2018 被引用: 510

  15. Advances in technology for management of type 1 diabetes

    著者: , , , - The Lancet 2019 被引用: 238

  16. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Minu George, Edgar R. Gonzalez, Michael Gottschalk, Giancarlo Guido, Amir Ali Hassan, Eli Hershkovitz, Lina Huerta‐Saenz, Jin Soon Hwang, Jaime Orlando Ibarra Gomez, Lydia Irizarry Gonzalez, Nina Jain, David H. Jelley, Ho-Seong Kim, T. A. Kovalenko, Lori M. Laffel, Steven B. Leichter, Raphael Del Roio Liberatore, Jane Lynch, Farid H. Mahmud, Oleg Arturovich Malievskiy, Andrew Muir, Bryce Nelson, Luis Alejandro Nevarez Ruiz, Micah L. Olson, Emilia Susana Pelayo Orozco, Valentina Peterkova, Fernando Ramón Ramírez Mendoza, Konda Mohan Reddy, Henry Rodriguez, Javier Andres Saenz, Julia Samoilova, Karl‐Otfried Schwab, S Shah, Naim Shehadeh, Ashley H. Shoemaker, Yulia Skorodok, Aleksandr Sobolev, Silvana Ernestina Solís, Shylaja Srinivasan, William V. Tamborlane, Eva Tsalikian, Ф. В. Валеева, Carl D Vance, Pedro Velasquez‐Mieyer, R. Ortiz, Olga Votyakova, Haiyan Wei, Ruth S. Weinstock, Mark D. Wheeler, Brandy Wicklow, Steven M. Willi, Kupper A. Wintergerst, Risa M. Wolf, Jamie Wood, Chandan Yaliwal, Hernán Yupanqui Lozno - The Lancet Diabetes & Endocrinology 2023 被引用: 103

  17. Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association

    著者: , , , , - Diabetes Care 2014 被引用: 969

  18. Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey

    著者: , , , , , , , , , , , , , - Diabetes Care 2024 被引用: 89

  19. Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study

    著者: , , , , , , , - The Lancet Diabetes & Endocrinology 2022 被引用: 84

  20. Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Turcotte, Lisa K. Volkening, Melissa J. Schoelwer, Sue A. Brown, Katie Krauthause, Emma Emory, Mary Oliveri, Bruce A. Buckingham, Laya Ekhlaspour, Ryan Kingman, Amy Criego, Betsy L. Schwartz, Laura M. Gandrud, Aimee Grieme, Jamie Hyatt, Daniel J. DeSalvo, Siripoom McKay, Kylie DeLaO, Carolina Villegas, Sarah A. MacLeish, Jamie Wood, Beth A. Kaminski, Terri Casey, Wendy Campbell, Kim Behm, Ramon Adams, David W. Hansen, Sheri Stone, Suzan Bzdick, Jane Bulger, Lynn Agostini, Sarah Doolittle, Kaisa Kivilaid, Krista Kleve, Trang T. Ly, Bonnie Dumais, Todd Vienneau, Lauren M. Huyett, Joon Bok Lee, Jason O’Connor, Eric Benjamin - Diabetes Care 2022 被引用: 85

  21. Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mei Mei Church, Camille André, Molly Piper, David Lam, Grenye O’Malley, Camilla Levister, Selassie Ogyaadu, Jessica Lovett, Vinaya Simha, Vikash Dadlani, Shelly McCrady-Spitzer, Corey Reid, Kanchan Kumari, Gregory P. Forlenza, G. Todd Alonso, Robert H. Slover, Emily Jost, Laurel H. Messer, Cari Berget, Lindsey Towers, Alex Rossick-Solis, Tali Jacobson, Marissa Town, Ideen Tabatabai, Jordan Keller, Evalina Salas, Francis J. Doyle, Eyal Dassau, Samantha Passman, Tiffany Campos, Carlos Murphy, Nandan Patibandla, Sarah Borgman, Guillermo Arreaza-Rubín, Neal Green, Boris Kovatchev, Sue A. Brown, Stacey Anderson, Marc Breton, Lori Laffel, Jordan Pinsker, Carol J. Levy, R. Paul Wadwa, Bruce A. Buckingham, Francis Doyle, Eric Renard, Claudio Cobelli, Yves Reznik, Guillermo Arreaza-Rubín, John Lum, Roy W. Beck, Robert Janicek, Deanna Gabrielson, Steven H. Belle, Jessica R. Castle, Jennifer Green, Laurent Legault, Steven M. Willi, Carol Wysham, Thomas Eggerman - Diabetes Technology & Therapeutics 2020 被引用: 111

  22. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes

    著者: , , , - Diabetes Technology & Therapeutics 2018 被引用: 194

  23. Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents

    著者: , , , , , , , , , , - JAMA Pediatrics 2018 被引用: 186

  24. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring

    著者: , , , , , , , , , , , , - Pediatric Diabetes 2022 被引用: 90